Current Report Filing (8-k)
09 December 2016 - 12:09AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 or 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of report (Date of earliest event reported):
December 8, 2016
AdCare Health Systems, Inc.
(Exact Name of Registrant as Specified in Charter)
|
|
|
|
|
|
Georgia
|
|
001-33135
|
|
31-1332119
|
(State or Other Jurisdiction of
Incorporation)
|
|
(Commission File Number)
|
|
(I.R.S. Employer
Identification No.)
|
|
|
454 Satellite Boulevard
Suite 100
Suwanee, Georgia 30024
|
|
|
(Address of Principal Executive Offices)
|
|
|
|
|
|
(678) 869-5116
(Registrant’s telephone number, including area code)
Not applicable.
(Former Name or Former Address, if Changed Since Last Report)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
|
|
|
|
¨
|
|
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
|
|
|
|
¨
|
|
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
|
|
|
|
¨
|
|
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
|
|
|
|
¨
|
|
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
|
Item 7.01 Regulation FD Disclosure.
Attached as Exhibit 99.1 and furnished for purposes of Regulation FD is an updated Investor Presentation dated December 8, 2016. In accordance with general instruction B.2 of Form 8-K, the information in Item 7.01 of this Current Report on Form 8-K (including Exhibit 99.1) is furnished and shall not be deemed to be “filed” for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”), or otherwise subject to the liability of that section, nor shall it be deemed to be incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act.
Item 9.01
Financial Statements and Exhibits.
(d) Exhibits.
99.1 Investor Presentation dated December 8, 2016.
SIGNATURES
Pursuant to the requirements of the Securities and Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
|
|
|
Date: December 8, 2016
|
ADCARE HEALTH SYSTEMS, INC.
|
|
|
|
|
|
|
|
|
/s/ Allan J. Rimland
|
|
|
|
Allan J. Rimland
|
|
|
President and Chief Financial Officer
|
EXHIBIT INDEX
|
|
|
|
Exhibit No.
|
|
Exhibit Description
|
99.1
|
|
Investor Presentation dated December 8, 2016
|
Adcare Health Systems (GA) (delisted) (AMEX:ADK)
Historical Stock Chart
From Oct 2024 to Nov 2024
Adcare Health Systems (GA) (delisted) (AMEX:ADK)
Historical Stock Chart
From Nov 2023 to Nov 2024
Real-Time news about Adcare Health Systems (GA) (delisted) (American Stock Exchange): 0 recent articles
More Adcare Health Systems, Inc News Articles